Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers
Dow Jones2026/08/26 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Eli Lilly & Co. slipped 3.6% to $1,189.41 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,675.70 and the Dow Jones Industrial Average falling 0.2% to 53,463.88.
This was the stock's third consecutive day of losses.
Eli Lilly & Co. closed 8.0% below its 52-week high of $1,292.65, which the company reached on August 19th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and AbbVie Inc. fell 1.09% to $262.90.
Trading volume totaled 3.0 million, compared to the 50-day average of 2.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 26, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
North Sea Oil Premiums Hit Records As Saudi Sales Shift
Anthropic plans to launch its initial public offering in November
Volkswagen plunges! Profit forecast for 2026 significantly lowered, Porsche writes down €6 billion
Volkswagen expects the Group's operating sales return in 2026 to reach a maximum of only 1%, far below the previously projected 4% to 5.5%. The company anticipates that special items will impact full-year operating profit by about 10 billion euros, with around 6 billion euros attributable to non-cash impairments of goodwill in Porsche's operations. Increased competitiveness from Chinese automakers and accelerated consumer demand shift toward pure electric vehicles are also significant pressures facing Volkswagen. As a result of this news, Volkswagen's share price closed down 5.6% on Friday.
Crypto prices
More
